Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases
Plasma cell differentiation (PCD) is frequently observed in some entities of non-Hodgkin B cell lymphoma, including both low-grade and high-grade lymphomas. However, except for plasmablastic lymphoma and primary effusion lymphoma, EBV + B cell lymphoproliferative disorder (LPD) with PCD has not been...
Saved in:
Published in | Virchows Archiv : an international journal of pathology Vol. 478; no. 5; pp. 969 - 976 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2021
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Plasma cell differentiation (PCD) is frequently observed in some entities of non-Hodgkin B cell lymphoma, including both low-grade and high-grade lymphomas. However, except for plasmablastic lymphoma and primary effusion lymphoma, EBV
+
B cell lymphoproliferative disorder (LPD) with PCD has not been well addressed due to its rarity. We clinicopathologically examined five cases of nodal EBV
+
polymorphic B cell LPD with PCD (PBLPD-PCD) initially diagnosed as polymorphic EBV
+
diffuse large B cell lymphoma, not otherwise specified (DLBCL-NOS) with PCD (
n
= 3) and methotrexate-associated B cell LPD (MTX-associated B-LPD) (
n
= 2). One case had a concomitant brain lesion which was clinically diagnosed as EBV-related encephalitis. This patient received therapy with vidarabine, and both the brain lesion and the nodal EBV
+
PBLPD-PCD lesions disappeared. Another case was characterized by Mott cell differentiation. This case was the first reported case of EBV
+
B cell lymphoma or LPD with Mott cell differentiation. The two cases of MTX-associated B cell LPD which arose in patients with rheumatoid arthritis spontaneously regressed after MTX cessation.
TCRγ
and
IGH
PCR analysis was performed in four cases. Two cases had
TCRγ
rearrangements, but no
IGH
rearrangements. The other two cases had no rearrangements in these genes. We concluded that nodal EBV
+
PBLPD-PCD is rare, with heterogeneous characteristics. PCR analysis revealed that nodal EBV
+
PBLPD-PCD may have only
TCR
clonality and no
IGH
clonality. Considering the partial or complete loss of CD20 expression on the tumor cells, this result may be confusing for accurate diagnosis of EBV
+
PBLPD-PCD, and pathologists need to be aware of this phenomenon to avoid misdiagnosis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0945-6317 1432-2307 |
DOI: | 10.1007/s00428-020-02967-6 |